Taysha Gene Therapies Inc. (TSHA)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 70
+0.01
+0.1757%
After Hours
$
+0.25 +4.386% 5. 95
1.82B Market Cap
- P/E Ratio
- Div Yield
1.76M Volume
-0.41 Eps
$ 5.69
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JA Jack Allen Baird | 1,153.98 | $7,409.17 | $6,300.76 | -$1,108.41 | -14.96% |
| KT Keith Tapper BMO Capital | 14,781.53 | $101,401.27 | $80,707.13 | -$20,694.14 | -20.41% |
